Literature DB >> 23823028

Potential utility of mutant oncogene-specific antibodies in melanoma.

Michael J Murphy1, Zendee Elaba.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 23823028     DOI： 10.1097/DAD.0b013e318292b396

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN： 0193-1091            Impact factor:   1.533


× No keyword cloud information.
  1 in total

1.  SP174 Antibody Lacks Specificity for NRAS Q61R and Cross-Reacts With HRAS and KRAS Q61R Mutant Proteins in Malignant Melanoma.

Authors:  Anna Felisiak-Goląbek; Shingo Inaguma; Artur Kowalik; Bartosz Wasąg; Zeng-Feng Wang; Sebastian Zięba; Liliana Pięciak; Janusz Ryś; Janusz Kopczynski; Maarit Sarlomo-Rikala; Stanislaw Góźdź; Jerzy Lasota; Markku Miettinen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2018-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.